CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that the Company has been upgraded to trade on the NASDAQ Global Select Market, the top listing tier for NASDAQ companies with the highest initial listing standards of any exchange in the world based on financial and liquidity requirements. Shares of ARIAD common stock will begin trading on the NASDAQ Global Select Market effective today.
